SUNNYVALE, Calif., April 23 /PRNewswire-FirstCall/ -- Accuray Incorporated, a global leader in the field of radiosurgery, announced today that French and Italian Health Authorities recently ruled that CyberKnife treatments will now be reimbursed throughout France and the Lombardy region of Italy for the treatment of tumors located anywhere in the body. These decisions demonstrate the increasing recognition amongst European Health Authorities of the critical role that the CyberKnife System plays in the treatment of patients with inoperable and complex tumors.
